JPMorgan Chase & Co. Analysts Give Reckitt Benckiser Group (LON:RB) a GBX 9,000 Price Target

Share on StockTwits

JPMorgan Chase & Co. set a GBX 9,000 ($117.60) price objective on Reckitt Benckiser Group (LON:RB) in a report released on Thursday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

Several other research analysts have also recently weighed in on the company. Deutsche Bank restated a hold rating and issued a GBX 1,775 ($23.19) price target on shares of in a research note on Wednesday, June 26th. Morgan Stanley restated an overweight rating on shares of in a research note on Thursday, June 20th. Credit Suisse Group restated a hold rating on shares of FactSet Research Systems in a research note on Monday, July 8th. Jefferies Financial Group upgraded AGCO from a hold rating to a buy rating and boosted their price target for the stock from $70.00 to $90.00 in a research note on Monday, June 24th. Finally, Goldman Sachs Group set a GBX 6,870 ($89.77) price target on Reckitt Benckiser Group and gave the stock a neutral rating in a research note on Tuesday, June 25th. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and twelve have given a buy rating to the stock. The company presently has an average rating of Hold and an average target price of GBX 7,211.11 ($94.23).

Shares of LON:RB opened at GBX 6,595 ($86.18) on Thursday. The company’s fifty day moving average is GBX 6,384.22. The stock has a market capitalization of $46.76 billion and a PE ratio of 21.64. Reckitt Benckiser Group has a 12-month low of GBX 5,559 ($72.64) and a 12-month high of GBX 7,174 ($93.74). The company has a quick ratio of 0.47, a current ratio of 0.65 and a debt-to-equity ratio of 80.49.

In related news, insider Adrian Nevil Hennah sold 13,701 shares of the company’s stock in a transaction on Friday, May 10th. The stock was sold at an average price of GBX 6,143 ($80.27), for a total transaction of £841,652.43 ($1,099,767.97). Also, insider Christopher Sinclair acquired 1,076 shares of Reckitt Benckiser Group stock in a transaction that occurred on Thursday, May 23rd. The shares were purchased at an average price of GBX 6,375 ($83.30) per share, with a total value of £68,595 ($89,631.52).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

See Also: Earnings Reports

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Barry Zwarenstein Sells 7,663 Shares of Five9 Inc  Stock
Barry Zwarenstein Sells 7,663 Shares of Five9 Inc Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc  Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc Stock
Insider Selling: Neogen Co.  Director Sells 5,000 Shares of Stock
Insider Selling: Neogen Co. Director Sells 5,000 Shares of Stock
Neogen Co.  Director Sells $314,650.00 in Stock
Neogen Co. Director Sells $314,650.00 in Stock
Insider Selling: Airgain Inc  CEO Sells 22,464 Shares of Stock
Insider Selling: Airgain Inc CEO Sells 22,464 Shares of Stock
Insider Selling: Bottomline Technologies  Insider Sells 9,925 Shares of Stock
Insider Selling: Bottomline Technologies Insider Sells 9,925 Shares of Stock


© 2006-2019 Ticker Report